Viral Vector Services

Andelyn Biosciences collaborates closely with you throughout the entire development and commercialization process of your cell and gene therapies, from initial research and development to establishing a dependable clinical and commercial supply. With expertise in viral vector production, process optimization, and GMP manufacturing, we support you at every step, ensuring seamless development and manufacturing for your therapy.

GMP Viral Vector Manufacturing

Featuring Andelyn’s AAV Curator™ platform, cell culture, and purification expertise, formulation, automated fill and finish, an experienced MSAT team, and the highest standards for quality control, quality assurance, and regulatory support, we deliver cost-effective solutions tailored to your needs.

75+ INDs
Approved
Multiple Decades
of Gene therapy Manufacturing
450+ cGMP
Clinical Batches
PPQs
Material  Supporting BLA Filling
225k
Combined Square Feet of Facility Space

GMP Scales

Suspension cGMP Manufacturing equipment
Adherent cGMP Manufacturing equipment
Facilities

Andelyn Corporate Center

Step inside the Andelyn Corporate Center (ACC), our clinical and commercial production facility built for the rigors of cell and gene therapy manufacturing. With the latest advances in GMP compliance, the ACC is currently producing high-quality viral vectors, including adeno-associated virus (AAV) and other viral vectors, optimized for clinical trials and large-scale production. Discover how our facility reliably advances the path to market for life-saving gene therapy products through optimized and industrialized processes.

Explore the Facility

High-Throughput Approach for Research and Toxicology Grade Vector

Suspension Processes

Standard Suspension Scales

Research Grade and TOX Grade Productions

  • 50L Suspension
  • 200L Suspension
  • Enhanced Documentation (TOX)
  • Enhanced Testing (TOX)
Adherent Processes

Standard Adherent Preps

  • HYPERStack® Cell Culture Vessels
  • 5HS to 30HS (GMP sublot scale)
  • Enhanced Documentation (TOX)
  • GMP Grade Materials (TOX)
  • Enhanced Testing (TOX)

Late-Stage Capabilities for
Your Vector Program

Our GMP facility accommodates programs from Phase 1 to late-stage and commercial production, avoiding facility changes and tech transfers throughout the regulatory stages of your program journey.

Process Characterization (PC)

workflow icon
Andelyn’s Approach

Based on client’s requirements and Filing Strategy

Modular & Bespoke PC Programs for flexibility and Speed

High-Throughput Technologies including Ambr® system

Supported by robust analytics

key activities icon
Key Activities

CQA (Critical Quality Attributes) Identification

FMEA (Failure Modes & Effects Analyses)

Analytical method qualification

Scale Down Models

DoE (Design of Experiment) Studies

Intermediate & Media Stability Studies

validation icon
Validation

Support to definition of Program’s Validation Strategy

Process Performance Qualification (PPQ) Runs

Analytical assays Validation

Commercial ready facility

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.